FIELD: medicine.
SUBSTANCE: pharmaceutical composition contains drug substances and a consistency-forming base. According to the invention, it contains anaesthetics as drug substances specified in a group: anaesthesine, lidocaine, promedol and antiseptic specified in a group of: ethacridine lactate, Furacilin, dioxidine, chlorhexidine, boric acid, 0.5% silver solution in the following ratio, g in 1 ml of the mixture: anaesthetics 0.00001-0.5; antiseptics 0.00001-0.5; consistency-forming base - the rest. Besides, it contains lysozyme in an amount of 0.1-0.3 g per 1 ml of the mixture, alpha-lipoic acid as an antioxidant in an amount of 0.00001-0.5 g per 1 ml of the mixture, regenerants specified in a group of: pantothenic acid, calcium pantotenate, beta-carotene, coenzyme Q, sodium deoxyribonucleate, inosine, vitamins A, D, E, K in an amount of 0.00001-0.5 g per 1 ml of the mixture, anabolics specified in a group of: methyluracil, riboxinum, potassium orotate, orotic acid, L-carnitine in an amount of 0.00001-0.5 g per 1 ml of the mixture, glycyrrhizic acid and/or its salts in an amount of 0.00001-0.5 g per 1 ml of the mixture, recombinant interferon specified in a group of: recombinant interferon-alpha, recombinant interferon-beta, recombinant interferon-gamma in an amount of 100-1,000,000 International units, glucocorticoids specified in a group of: hydrocortisone, prenisolone, polcortolone in an amount of 0.00001-0.5 g per 1 ml of the mixture. The consistency-forming base contains the components specified in a group: hypromellose, sodium alginate, acetyl phthalyl cellulose, macrogol, polyvinylpyrrolidone.
EFFECT: improving the properties of the composition.
9 cl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING INDIVIDUALS SUFFERING XEROSTOMIA | 2013 |
|
RU2538699C1 |
GEL FORMULATION FOR WOUNDS AND BURNS OF VARIOUS AETHIOLOGIES ENABLING EPITHELISATION | 2012 |
|
RU2496478C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING GASTRODUODENAL ULCER, POSSESSING IMMUNOMODULATORY, ANTIVIRAL, ANTIBACTERIAL, ANTI-INFLAMMATORY, ANTIOXIDANT AND REGENERATIVE EFFECT IN FORM OF TABLETS, CAPSULES OR GEL | 2013 |
|
RU2538697C1 |
JELLY PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECTIC BLEPHARITIS AND BLEPHAROCONJUNCTIVITIS | 2013 |
|
RU2533274C1 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING INFECTIOUS-INFLAMMATORY DISEASES OF VARIOUS ORIGINS BY OROMUCOSAL ADMINISTRATION | 2013 |
|
RU2538433C1 |
THERAPEUTIC AGENT FOR ORAL CLEANING IN INDIVIDUALS SUFFERING XEROSTOMIA, POSSESSING ANTISEPTIC ACTION AS SPRAY, GEL AND MOUTHWASH | 2013 |
|
RU2537034C1 |
AUTOGRAFT PRESERVING COMPOSITION | 2013 |
|
RU2533000C1 |
THERAPEUTIC AGENT IN FORM OF GEL FOR TREATING HERPETIC INFECTION MANIFESTATIONS IN PATIENTS WITH BURNS AND COLD INJURIES | 2013 |
|
RU2544163C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING TROPHIC ULCERS AND PERSISTENT WOUNDS OF VARIOUS ORIGINS IN FORM OF OINTMENT | 2013 |
|
RU2539383C1 |
ANTISEPTIC AND ANALGESIC THERAPEUTIC AGENT IN FORM OF GEL FOR PROCESSING AND LUBRICATING CATHETERS USED IN EXAMINING AND TREATING UROGENITAL SYSTEM | 2013 |
|
RU2540921C1 |
Authors
Dates
2015-04-10—Published
2014-03-24—Filed